Login / Signup
Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2.
Yifan Lin
Jing Sun
Xuezhi Cao
Xiuye Wang
Xi Chen
Hairong Xu
Jin-Cun Zhao
Yang-Xin Fu
Hua Peng
Published in:
Cell discovery (2022)
Keyphrases
</>
sars cov
respiratory syndrome coronavirus
dendritic cells
protein protein
chronic rhinosinusitis
amino acid
binding protein
coronavirus disease
immune response